| __timestamp | ACADIA Pharmaceuticals Inc. | MiMedx Group, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 32748000 | 90480000 |
| Thursday, January 1, 2015 | 90804000 | 133384000 |
| Friday, January 1, 2016 | 186456000 | 179997000 |
| Sunday, January 1, 2017 | 255062000 | 220119000 |
| Monday, January 1, 2018 | 265758000 | 258528000 |
| Tuesday, January 1, 2019 | 325638000 | 198205000 |
| Wednesday, January 1, 2020 | 388661000 | 181022000 |
| Friday, January 1, 2021 | 396028000 | 198359000 |
| Saturday, January 1, 2022 | 369090000 | 208789000 |
| Sunday, January 1, 2023 | 402466000 | 211124000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical landscape, operational efficiency is paramount. Over the past decade, ACADIA Pharmaceuticals Inc. and MiMedx Group, Inc. have showcased contrasting trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, ACADIA's SG&A expenses surged by over 1,100%, peaking in 2023. This reflects their aggressive expansion and investment in operational capabilities. In contrast, MiMedx Group's expenses grew by approximately 133%, indicating a more conservative approach. Notably, in 2017, MiMedx's SG&A expenses were at their highest, nearly matching ACADIA's. However, by 2023, ACADIA's expenses were almost double those of MiMedx. This divergence highlights differing strategic priorities and market responses. As the pharmaceutical industry continues to face challenges, understanding these financial dynamics offers valuable insights into corporate strategies and market positioning.
Selling, General, and Administrative Costs: Novo Nordisk A/S vs MiMedx Group, Inc.
Jazz Pharmaceuticals plc vs MiMedx Group, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Halozyme Therapeutics, Inc. vs MiMedx Group, Inc.
Breaking Down SG&A Expenses: Blueprint Medicines Corporation vs ACADIA Pharmaceuticals Inc.
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs ACADIA Pharmaceuticals Inc. Trends and Insights
Comparing SG&A Expenses: Alkermes plc vs MiMedx Group, Inc. Trends and Insights
Comparing SG&A Expenses: Verona Pharma plc vs MiMedx Group, Inc. Trends and Insights
ADMA Biologics, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? ACADIA Pharmaceuticals Inc. or MannKind Corporation
Cost Management Insights: SG&A Expenses for ACADIA Pharmaceuticals Inc. and Geron Corporation
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and BioCryst Pharmaceuticals, Inc.
ACADIA Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends